Seer Inc. will attend and present at the 2026 U.S. Human Proteome Organization (US HUPO) Annual Conference in St. Louis, Missouri, running February 21–25, 2026, where researchers will share findings enabled by Seer’s Proteograph® Product Suite across cardiovascular disease, neurodegeneration, aging biology, oncology, and scalable clinical proteomics workflows. More information is available here: https://www.globenewswire.com/Tracker?data=zkCu5QebRK1Quj7FYlxrKachXwwxkA0mVBmlikcV1CE8Y3UJ9YzFu3ALY7c_tDp-WmKYKeZ9_FKTddrKkek9hDdIokrkGwjB4z_p53h22OZLXUwi9h2EAhHqrb5uiqnuUCpjVvMKraLPvF9SzbuIMVaqMsrsrIrD4kEf522cjGNegwn1o3itYf60Vhba261hjIohRbarhehsnlUw1rTI2SXwEq-9lUpiNyWQC5y7ROwqgTvHgFEmdxlnM-OKuYKZ0k3I4pbssiRPS-iegeBfHI7YdB6sZytC3dKhnvWKc3Aqu1Z_eUN3dwZDXSFHYBmPVjPZH_10VTZmzuwOYuhwLAZlChEVzF4CjDX2pDgb1Xr3ghzf_fHt2CFkMA3IgtZB
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seer Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9657398-en) on February 19, 2026, and is solely responsible for the information contained therein.